Clinical trial
HEC113995-A Phase I,Double-Blind, Placebo-Controlled, Multiple Oral Dose, Safety, Tolerability, Pharmacokinetics and Food Effect Study in Healthy Chinese Subjects
NCT04623814 is registered in ClinicalTrials.gov with Sunshine Lake Pharma Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HEC113995-A Phase I,Double-Blind, Placebo-Controlled, Multiple Oral Dose, Safety, Tolerability, Pharmacokinetics and Food Effect Study in Healthy Chinese Subjects
- Lead sponsor
- Sunshine Lake Pharma Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 30, 2020
- Completion date
- August 12, 2020
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.